Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer.
Anido-Herranz U, Fernandez-Calvo O, Ruiz-Bañobre J, Martinez-Breijo S, Fernandez-Nuñez N, Nogareda-Seoane Z, Garrido-Pumar M, Casas-Nebra J, Muñiz-Garcia G, Portela-Pereira P, Gomez-Caamaño A, Perez-Fentes DA, Santome-Couto L, Lázaro M, Molina-Diaz A, Medina-Colmenero A, Vazquez-Estevez S.
Anido-Herranz U, et al. Among authors: fernandez calvo o.
Front Oncol. 2024 May 7;14:1385466. doi: 10.3389/fonc.2024.1385466. eCollection 2024.
Front Oncol. 2024.
PMID: 38774416
Free PMC article.